These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17445398)

  • 1. [Chinese expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular diseases].
    ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):97-106. PubMed ID: 17445398
    [No Abstract]   [Full Text] [Related]  

  • 2. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
    Novikova LS; Arabidze GG
    Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitor therapy.
    Róna G
    Ther Hung; 1991; 39(2):63-70. PubMed ID: 1948779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of angiotensin converting enzyme inhibitors.
    Chatterjee K
    Heart Dis Stroke; 1992; 1(3):128-33. PubMed ID: 1344097
    [No Abstract]   [Full Text] [Related]  

  • 7. Current indications for ACE inhibitors and HOPE for the future.
    Burch S; Ou N
    Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases.
    Gavras H
    N Engl J Med; 1988 Dec; 319(23):1541-3. PubMed ID: 3185679
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease].
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C; Priori SG; Alonso García MA; Blanc JJ; Budaj A; Cowie M; Dean V; Deckers J; Fernández Burgos E; Lekakis J; Lindahl B; Mazzotta G; McGregor K; Morais J; Oto A; Smiseth OA; Ardissino D; Avendano C; Blomström-Lundqvist C; Clément D; Drexler H; Ferrari R; Fox KA; Julian D; Kearney P; Klein W; Köber L; Mancia G; Nieminen M; Ruzillo W; Simoons M; Thygesen K; Tognoni G; Tritto I; Wallentin L; ;
    Rev Esp Cardiol; 2004 Dec; 57(12):1213-32. PubMed ID: 15617645
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular disease.
    Frishman WH
    Heart Dis; 2000; 2(3):183-4. PubMed ID: 11794142
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM; De Besse A
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ramipril on cardiovascular events in high-risk patients.
    Gavras H
    N Engl J Med; 2000 Jul; 343(1):65-6. PubMed ID: 10896546
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin-converting enzyme inhibitors: their application in cardiovascular diseases.
    Cerdeira AS; Brás-Silva C; Leite-Moreira AF
    Rev Port Cardiol; 2008 Mar; 27(3):385-408. PubMed ID: 18551924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular diseases. Improvement of the endothelial function as strategic therapeutic aim].
    Z Kardiol; 1998 Jun; 87(6 Suppl Besserung):1-4. PubMed ID: 9698652
    [No Abstract]   [Full Text] [Related]  

  • 18. ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?
    Pellizzer AM; Krum H
    Aust Fam Physician; 1996 Jul; 25(7):1067-9, 1072-3, 1076-7. PubMed ID: 8768273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Second International Symposium on Cilazapril. February 9 to 11, 1989, Basel, Switzerland. Proceedings.
    Am J Med; 1989 Dec; 87(6B):1S-99S. PubMed ID: 2532456
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.